Please assess the completion status of the following clinical trial:

Trial Title: A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have human leukocyte antigen (HLA)-A\*24:02~* Patients who have histologically-confirmed colorectal cancer (adenocarcinoma)~* Patients with advanced or relapsed colorectal cancer who are refractory or intolerant to standard chemotherapy~* Patients with an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 to 1 at the time of enrollment in the trial.~Exclusion Criteria:~* Patients who are HIV antibody test positive~* Patients with an active infection~* Patients who have or are suspected to have CNS metastasis of colon cancer (such as metastatis of the brain)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dose level 1 (Type: EXPERIMENTAL): None
- Dose level 2 (Type: EXPERIMENTAL): None
- Dose level 3 (Type: EXPERIMENTAL): None
- Dose level 4 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).